The investor piece cites retatrutide's 28.3% mean weight loss in an 80-week Phase 3 study and Lilly's push into combo and maintenance dosing.
Recap by typeshit. Full story at Yahoo Finance.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
The stock analysis puts Novo's P/E well under the 21.7x pharma average and asks whether recent semaglutide data justify a higher price.
A year after GLP-1 drugs reached India, the paper checks in on the so-called Mounjaro brides who used them before their weddings.
Loading…